RxDoctor Payments Data
★ My doctorsLook up a doctor →

Amaan Shafi

Internal Medicine · Las Vegas, NVNPI 1548796329

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Abbott accounts for 72.5% of it on its own, with 28 other manufacturers making up the rest. Among internal medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,282in general payments, 2019–2025

Across 246 payments — averaging $102.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Boston Scientific$1K
  • Abiomed$976
  • Biosense Webster, Inc.$734
  • Biotronik Inc.$591
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$548
  • plus $3K from 23 others

What the payments were for

  • Grants$5002%
  • Travel & lodging$11,31245%
  • Food & beverage$11,91947%
  • Education$1,4676%
  • Entertainment$840%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott143$18,323
Boston Scientific9$1,034
Abiomed6$976
Biosense Webster, Inc.18$734
Biotronik Inc.7$591
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)10$548
Medtronic4$424
Scpharmaceuticals Inc.3$334
Lantheus Medical Imaging, Inc.9$301
Novo Nordisk7$249
AstraZeneca5$191
Astellas Pharma US Inc2$189
E.r. Squibb & Sons, L.L.C.4$155
Cvrx, Inc.1$144
Edwards Lifesciences1$131
Pfizer1$124
Actelion Pharmaceuticals US, Inc.1$122
Johnson & Johnson1$120
Philips North America LLC1$106
Merck2$100
Stereotaxis Inc1$84
Chiesi USA, Inc.1$84
Esperion Therapeutics, Inc.1$43
Novartis2$43
Livanova USA, Inc.1$35
Boehringer Ingelheim1$33
Cardiovascular Systems Inc.2$25
Lexicon Pharmaceuticals, Inc.1$24
Itamar Medical Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,282 in reported general payments places this provider in the 95th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$10,485
Cephalexin15$218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$249$10,48511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,071 internal medicine providers in Nevada.

Other internal medicine in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →